Zobrazeno 1 - 10
of 357
pro vyhledávání: '"C, Riché"'
Autor:
A. Bizieux, Jean-Philippe Metges, Sophie Abadie-Lacourtoisie, Veronique Guerin-Meyer, Jean-Yves Douillard, Oana Cojocarasu, M. Kaassis, G. Ganem, O. Capitain, F. Grude, J. Baudon, C. Lafond, H. Morel, E. Blot, P. Ingrand, Fabrice Denis, M.E. Morin-Meschin, S. Corbinais, M. Marcq, L. Juhel-Voog, Valérie Delecroix, Anne-Claire Hardy-Bessard, M. Zinger, Patrick Soulié, Caroline Alleaume, Fanny Marhuenda, Y.H. Lam, R. Lamy, E. Gamelin, E. Voog, Emmanuelle Bourbouloux, Olivier Dupuis, D. Berton-Rigault, Julien Edeline, S. Lebouvier-Sadot, P. Maillart, M. Ferec, J.M. Commer, A. Gangler, B. d’Aillières, M.J. Goudier, J. Egreteau, Xavier Artignan, R. Delva, E. Naudeix, D. Déniel-Lagadec, C. Lefeuvre, C. Riché, F. Le Du, A. Zannetti, Philippe Deguiral, Hugues Bourgeois, P. Solal-Céligny
Publikováno v:
Annals of Oncology. 28:1612-1617
Background In 2008, a study of the characteristics of hospitalised patients led to the development of a prognostic tool that distinguished three populations with significantly different 2-month survival rates. The goal of our study aimed at validatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bfdb51cd99d498ae3513e78bdb12f8c
https://doi.org/10.1093/annonc/mdx172
https://doi.org/10.1093/annonc/mdx172
Autor:
Anne Mathieu-Boué, Pierre Demolis, Jean-François Bergmann, M. Aoustin, C. Atlani, F. Bassompierre, R. Benamouzig, M.-J. Bonavita, L. Borella, F. Calvo, C. Caulin, D. Cellier, M. Dahan, V. Daura, F. De Beels, N. De Vernejoul, V. Diebolt, N. Dumarcet, I. Durand Zaleski, E. Fery Lemonnier, J. Genève, I. Giri, D. Golinelli, C. Labreveux, J.-F. Latour, D. Maraninchi, V. Meresse, L. Mignot, D. Morlet, S. Pépin, P. Ravaud, C. Riché, A. Rouleau, P. Tilleul, P. Viens
Publikováno v:
Therapie. 61(4)
Drugs used in oncology represent more than half of the innovative and costly drugs which are not covered by a Group Homogene de Soins (DRG type classification) within the context of the case-mix based payment system (termed T2A). For these drugs, goo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca266e08379d0a664fbfb3face31cfd8
https://pubmed.ncbi.nlm.nih.gov/27393309
https://pubmed.ncbi.nlm.nih.gov/27393309
Autor:
Jean-Louis Montastruc, E Autret-Leca, B Baldin B, F Bavoux, A Bénard-Laribière, M Biour, MN Beyens, F Colin, A Cocquerel, S Crepin, G Décréau-Gaillon, S Dos Santos, P Eftekhari, S Favrelière, S Gautier, V Gras-Champel, L Javot, MJ Jean-Pastor, C Le Beller, B Lebrun-Vignes, A Millaret, A Perrazi, V Pinzani, C Riché, E Schir, C Sgro, M Tebacher-Alt, T Trenque, MB Valnet-Rabier, G Veyrac
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 195:1309-1317
RESUME Cette etude a evalue les notifications spontanees d’effets indesirables medicamenteux (EIM) collectees sur le territoire francais entre le 21 octobre 2009 et le 15 juin 2010 pour les vaccins antiviraux A (H1N1) v. Cette campagne s’est cara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10857f86a220d140681da1e8070d3676
https://doi.org/10.1016/s0001-4079(19)31991-0
https://doi.org/10.1016/s0001-4079(19)31991-0
Autor:
Anne Mathieu-Boué, Pierre Demolis, Jean-François Bergmann, M. Aoustin, C. Atlani, F. Bassompierre, R. Benamouzig, M.-J. Bonavita, L. Borella, F. Calvo, C. Caulin, D. Cellier, M. Dahan, V. Daura, F. De Beels, N. De Vernejoul, V. Diebolt, N. Dumarcet, I. Durand Zaleski, E. Fery Lemonnier, J. Genève, I. Giri, D. Golinelli, C. Labreveux, J.-F. Latour, D. Maraninchi, V. Meresse, L. Mignot, D. Morlet, S. Pépin, P. Ravaud, C. Riché, A. Rouleau, P. Tilleul, P. Viens
Publikováno v:
Therapies. 61:305-308
Les medicaments utilises en cancerologie representent plus de la moitie des medicaments innovants et couteux pris en charge hors d'un groupe homogene de soins dans le cadre de la tarification a l'activite. Pour ces medicaments, des referentiels de bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4014c868cef1c44a0788ee6dcdcd914
https://doi.org/10.2515/therapie:2006054
https://doi.org/10.2515/therapie:2006054
Autor:
H. S. Jhaveri, Denis Herbreteau, S. Slaba, J. J. Merland, A. Aymard, O. Enjolras, M. C. Riché, N. Aoun, Alfredo Casasco, Emmanuel Houdart
Publikováno v:
European Radiology. 8:280-285
Arteriovenous malformations (AVM) are developmental errors with a high complication rate because they are hemodynamically active. The aim of our study is to evaluate management of the rare subgroup of tongue AVM. From 1982 to 1994, 25 patients with A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b09e4a253055febaa7d40b352af8a29
https://doi.org/10.1007/s003300050380
https://doi.org/10.1007/s003300050380
Autor:
Deborah Szafir, Hervé Lelouët, Jean-Louis Imbs, R. Barouki, J.P. Blayac, B. Bons, J. Caron, A. Castot, M. Childs, V. Daurat, J. Deligne, C. Delmas, J.P. Demarez, E. Eschwege, A. Garcia-Gibot, F. Girard, J. Guilhot, C. Kreft-Jaïs, G. Lagier, V. Lamarque, B. Lebrun-Vignes, A. Lelouet, P. Maillère, J.L. Malvy, M. Mazraani, L. Moachon-Chauvelot, D. Muzard, P. Olivier, M. Pappo, E. Pastor, C. Riché, D. Sallière, L. Thomas
Publikováno v:
Therapies. 58:221-223
L'efficacite de la prevention d'un risque medicamenteux depend de la precision avec laquelle ses facteurs declenchants ou favorisants sont connus et de la qualite de l'information donnee a son sujet aux prescripteurs et aux utilisateurs. L'identifica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::535da247e9e06ee88411b0d1acf9eb22
https://doi.org/10.2515/therapie:2003035
https://doi.org/10.2515/therapie:2003035
Autor:
Deborah Szafir, Hervé Lelouët, Jean-Louis Imbs, R. Barouki, J.P. Blayac, B. Bons, J. Caron, A. Castot, M. Childs, V. Daurat, J. Deligne, C. Delmas, J.P. Demarez, E. Eschwege, A. Garcia-Gibot, F. Girard, J. Guilhot, C. Kreft-Jaïs, G. Lagier, V. Lamarque, B. Lebrun-Vignes, A. Lelouet, P. Maillère, J.L. Malvy, M. Mazraani, L. Moachon-Chauvelot, D. Muzard, P. Olivier, M. Pappo, E. Pastor, C. Riché, D. Sallière, L. Thomas
Publikováno v:
Therapies. 58:225-227
Effective prevention of drug-induced risks depends on an accurate understanding of their triggering or predisposing factors, and the quality of information on these available to prescribing practitioners and users. All preclinical and clinical data a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b749f0cef09b60a32342b5aff67c808
https://doi.org/10.2515/therapie:2003036
https://doi.org/10.2515/therapie:2003036
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Therapie. 56(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::133afa5e00a3b799b198a0f3de8f824c
https://pubmed.ncbi.nlm.nih.gov/11475807
https://pubmed.ncbi.nlm.nih.gov/11475807
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 26(8)
Irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine++ +] is a water-soluble analogue of camptothecine used in the second-line treatment of advanced colon cancer. Recently, we identified, in the plasma of patients and in hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28588ca727ea82af81d904140a447275
https://pubmed.ncbi.nlm.nih.gov/9698291
https://pubmed.ncbi.nlm.nih.gov/9698291